METASTATIC UROTHELIAL CANCER
Clinical trials for METASTATIC UROTHELIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC UROTHELIAL CANCER trials appear
Sign up with your email to follow new studies for METASTATIC UROTHELIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to outsmart chemo in tough bladder cancer
Disease control Recruiting nowThis study compares a new drug, izalontamab brengitecan, against standard platinum-based chemotherapy in 470 people with metastatic urothelial cancer that has worsened after immunotherapy. The goal is to see if the new drug can slow cancer growth or improve survival. Participants…
Matched conditions: METASTATIC UROTHELIAL CANCER
Phase: PHASE2, PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Promising drug targets Hard-to-Treat bladder cancer
Disease control Recruiting nowThis study tests a drug called sacituzumab govitecan in people with advanced bladder cancer that has spread and cannot be removed by surgery. The goal is to see if the drug can shrink tumors and control the cancer. About 827 adults with good organ function and a life expectancy o…
Matched conditions: METASTATIC UROTHELIAL CANCER
Phase: PHASE2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC